Roy C. Hardiman

CIK: 0001506218

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (25.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALMS

ALUMIS INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ALMS
ALUMIS INC.
Aug 3, 2026
Sale(S)
Direct
2.7K shares at avg. $26.37$71K
ALMS
ALUMIS INC.
Jan 26, 2026
Award(A)
Stock Option (Right to Buy)
Direct
190.9K shares-
ALMS
ALUMIS INC.
Jul 29, 2025
Award(A)
Direct
28K shares-
ALMS
ALUMIS INC.
Feb 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
140K shares-

		Type	Shares	Price		Ownership
Aug 3, 2026	ALMS ALUMIS INC.	Sale(S)	2,692	$26.37	$70,988	Direct
Jan 26, 2026	ALMS ALUMIS INC.	Award(A) Stock Option (Right to Buy)	190,875	-	-	Direct
Jul 29, 2025	ALMS ALUMIS INC.	Award(A)	28,000	-	-	Direct
Feb 18, 2025	ALMS ALUMIS INC.	Award(A) Stock Option (Right to Buy)	140,000	-	-	Direct

1-4 of 4 transactions

About Hardiman Roy C.

Hardiman Roy C. (SEC CIK 0001506218) files insider reports with the SEC as Chief Business & Strategy Ofcr of ALUMIS INC. (ALMS).

Signal8 holds 4 ownership filings by Hardiman Roy C., all Form 4s, filed between Feb 20, 2025 and Aug 5, 2026. Those filings report 4 transactions, from Feb 18, 2025 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Hardiman Roy C.'s filings is in SOUTH SAN FRANCISCO, CA.

Recent filings by Hardiman Roy C.

Aug 3, 2026: Open-market sale of ALMS shares (Form 4, code S).
Jan 26, 2026: Grant or award of ALMS derivative securities (Form 4, code A).
Jul 29, 2025: Grant or award of ALMS shares (Form 4, code A).
Feb 18, 2025: Grant or award of ALMS derivative securities (Form 4, code A).

Other insiders filing for ALUMIS INC. (ALMS)

AKKARAJU SRINIVAS, Director
Schroer John R., Chief Financial Officer
Pangali Sanam, Chief Legal Officer
Goldstein David M, Chief Scientific Officer
Drappa Jorn, Chief Medical Officer
Bradley Mark Christopher, Chief Development Officer

How to read Form 4 transaction codes